Vitamin B12 markets in the United States slipped modestly late February after range-bound activity, amid cautious imports and steady distributor inventories that kept supply balanced. Early and mid-month trading featured routine replenishment and steady offshore production that supported discipline, while late-month sentiment softened as buyers retrenched from incremental coverage. The February narrative centred on steady underlying demand from nutraceutical and fortified-food formulators, offset by conservative purchasing from traders and importers, resulting in limited spot activity within a narrow band. Demand dynamics for CFR Los Angeles were a key driver of the month's level, with a monthly assessment showing a modest uptick from the prior reference, even as weekly readings fluctuated. Industry data indicated a cautious but resilient market, with supply cycles remaining regular and no major disruptions reported. Looking forward, upside and downside risks depend on importer coverage, distributor inventory behaviour, and offshore shipment schedules. A bullish bias persists on a moving average, with direction tied to buyer risk appetite.
